ESSA Pharma Future Growth
How is ESSA Pharma forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?
Future Growth Score0/6
Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
|Date||Revenue||Earnings||Free Cash Flow||Cash from Op||Avg. No. Analysts|
Analyst Future Growth Forecasts
Earnings vs Savings Rate: EPIX is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: EPIX is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: EPIX is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: EPIX is forecast to have no revenue next year.
High Growth Revenue: EPIX is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if EPIX's Return on Equity is forecast to be high in 3 years time